Results 191 to 200 of about 209,267 (264)

Production of 177Lu for Targeted Radionuclide Therapy: Available Options

Nuclear medicine and molecular imaging, 2015
A. Dash, M. R. Pillai, F. F. Knapp
semanticscholar   +1 more source

Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small‐intestinal and pancreatic NETs

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Liver transplantation (LT) may offer survival or symptomatic benefit for highly selected patients with advanced, well‐differentiated small‐intestinal or pancreatic neuroendocrine tumours and unresectable liver‐dominant metastases. However, its role remains controversial, as LT is rarely curative, recurrence is common, and benefits must be ...
Peter Stålberg, Mairéad G. McNamara, Simona Grozinsky‐Glasberg, Andreas Pascher, Beata Kos‐Kudla, Timm Denecke, Nehara Begum, Wendy Martin, Stephanie Alband, Clarisse Dromain, Raj Srirajaskanthan, Eric Baudin   +11 more
wiley   +1 more source

Dodder seedlings benefit from apoplastic nutrition by inducing SWEET15‐mediated unloading of sucrose from the host's phloem

New Phytologist, Volume 252, Issue 2, Page 829-842, October 2026.
Cuscuta reflexa infection sites. Summary Cuscuta species are holoparasitic plants that penetrate host stems with haustoria, connect to the vasculature and exhaust water, nutrients and carbohydrates. Parasite seedlings possess only limited maternal reserves and the development of a vascular connection takes several days.
Maleen Hartenstein, Dominik Eydam, Antonia Klatt, Arne Greif, Peter Slaby, Ronja Burggraf, Franz Klebl, Isabell Albert, Uwe Sonnewald, Ruth Stadler, Markus Albert   +10 more
wiley   +1 more source

Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors.

Hematology/Oncology Clinics of North America, 2016
D. Kwekkeboom, E. Krenning
semanticscholar   +1 more source

Insurability under uncertainty: A technology‐readiness and safe‐by‐design framework for engineered nanomaterials

Risk Management and Insurance Review, Volume 29, Issue 3, Page 294-307, Fall 2026.
Abstract Engineered nanomaterials promise transformative benefits across manufacturing, medicine, energy, and environmental remediation, yet they advance faster than the safety knowledge needed to price and transfer their hazards. The problem they pose runs deeper than measurable risk.
Benjamin Trump, Joshua Trump, Carla Carona, Dalila Antunes, José Palma‐Oliveira, Igor Linkov, Jeffrey Keisler   +6 more
wiley   +1 more source

Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. [PDF]

Molecules
Kono Y, Utsunomiya K, Kariya S, Tanigawa N.   +3 more
europepmc   +1 more source

Non-thermal gliding arc plasma for cesium-137 mobilization and radiological risk reduction in electric arc furnace dust. [PDF]

RSC Adv
Rathore V, Yubonmhat K, Tamman A, Choomjun D, Masae S, Bor-In P, Nilgumhang K, Kongprawes G, Barkhade T, Zala AB, Gopinath SCB, Adam T, Zaaba SK, Bhabhor F, Chattaraj S, Nisoa M.   +15 more
europepmc   +1 more source

Radionuclide Imaging of Musculoskeletal Infection: A Review

Journal of Nuclear Medicine, 2016
C. Palestro
semanticscholar   +1 more source

Auger-Emitting Radionuclides in Radiopharmaceutical Research: Decay-Associated Processes, Vector-Dependent Localization, and Translational Perspectives. [PDF]

Int J Mol Sci
Schomäcker K, Sudbrock F, Freifrau von Brandenstein M, Akgül B, Hufbauer M, Fischer T, Sahnoun SEM, Dietlein F, Krapf P, Dietlein M, Drzezga A.   +10 more
europepmc   +1 more source